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Recent studies indicate that in several regions
of the world, arsenic concentration in water is
much higher than accepted levels (Smedley
and Kinniburgh 2002). The concern with As
contamination of drinking water is that con-
sumption and use of this water in cooking can
increase As exposure in humans (Del Razo
et al. 2002). In Mexico, the amount of this
contaminant in ground water varies from 10 to
5,000 µg/L (Del Razo et al. 1990). Del Razo
et al. (1990; 1994) reported on the problem of
As-contaminated groundwater in the Lagunera
Region of northern Mexico, with >50% of
samples having As concentrations >50 µg/L,
which was the former level of reference set by
the World Health Organization (International
Programme on Chemical Safety 2001). The
predominant type of As in 90% of the samples
was pentavalent arsenic.
In 1977, the presence of As in potable
water was reported in the city of Torreón, the
main city in the Region Lagunera and the site
of the most important metallurgic complex of
Mexico. As concentration in Torreón’s water
was up to 4–6 mg/L, far above the present
10-µg/L limit (Cebrian et al. 1994; Mandal
and Suzuki 2002). Benin et al. (1999) evalu-
ated heavy metal contamination of soil in
three residential areas that surround the
smelter and found that As levels had a
median of 113 µg/g, and ranged from 78 to
287 µg/g. These levels exceeded the level at
which the U.S. Environmental Protection
Agency (EPA) designated cleanup goals for
Superfund sites, 5–65 µg/g (U.S. EPA 1997).
Approximately 60–90% of the soluble
inorganic arsenic (InAs) components are
absorbed through the gastrointestinal tract
(Hall 2002). In humans, InAs metabolism
involves at least ﬁve metabolites that can exert
toxic effects (Valenzuela et al. 2005). The
measure of urinary As (UAs) excretion is a
good biomarker for chronic exposure via
drinking water [Agency for Toxic Substances
and Disease Registry (ATSDR) 2000]. As
concentration in urine, normally < 10 µg/L,
can reach as high as 50 µg/L in adults and
children living close to metal foundries
(Carrizales et al. 2006; Polissar et al. 1990). 
The negative consequences of As exposure
in humans include respiratory, gastrointestinal,
hematologic, hepatic, renal, dermic, neuro-
logic, and immunologic effects (ASTDR 2000;
Garcia-Vargas and Hernandez-Zavala 1996;
International Programme on Chemical Safety
2001), many of which continue even after the
contaminant source is controlled (Diaz-Barriga
et al. 1997). As can also have detrimental
effects on the central nervous system and cog-
nitive development in children (International
Programme on Chemical Safety 2001). Acute
As exposure affects sensory nerves as well as the
long axon neurons, which results in the clinical
manifestation of numb extremities. Neurologic
tests have shown nerve axonophathy and
demyelination (Franzblau and Lilis 1989;
Rodriguez et al. 2003; Yung 1984). As also
affects the content of brain monoamines, and
the concentrations of dopamine and serotonin
in the hippocampus, hypothalamus, cerebral
cortex, and the striatum (Itoh et al. 1990;
Mejía et al. 1997; Rodríguez et al. 2003).
Few reports have suggested a detrimental
effect of As exposure on cognitive develop-
ment and function, including disturbed visual
perception, problems with visuomotor inte-
gration, psychomotor speed, attention,
speech, and memory. (Calderón et al. 2001;
Rodriguez et al. 2003; Tsai et al. 2003). In
this regard, the effects of As are similar to and
could be confounded with the effects of other
environmental contaminants such as lead. In
fact, in many regions of the world, As expo-
sure co-occurs with exposure to other conta-
minants such as lead (Carrizales et al. 2006;
Diawara et al. 2006). Poorer performance on
a range of cognitive tests has been reported in
children with low to moderate lead exposure
in Torreón (Kordas et al. 2004) and other
settings (Canfield et al. 2003; De Burbure
2006; Lanphear et al. 2000). 
In this study we identified demographic
and nutritional factors that are associated with
UAs concentration in school-age children. We
also investigated the inﬂuence of As exposure
on cognitive function in these children.
Methods
Subjects and design of the study. The study
sample consisted of 602 children 6–8 years of
age who attended first grade in nine public
elementary schools located within 3.5 km of a
metallurgic smelter complex in the city of
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BACKGROUND: Previous studies have suggested an effect of high arsenic concentration on cognitive
and neurobehavioral function in humans.
OBJECTIVE: Our goal was to identify demographic and nutritional factors that are associated with
As exposure and the inﬂuence of this exposure on cognitive function in school-age children. 
METHODS: We recruited 602 children 6–8 years of age living within 3.5 km of a metallurgic
smelter complex in the city of Torreón, Mexico, to participate in a cross-sectional evaluation. Of
these, 591 had complete anthropometry, iron, and zinc status by biochemical measurements in
serum, blood lead concentration (PbB), and arsenic in urine (UAs), and 557 completed several cog-
nitive performance tests. 
RESULTS: The mean for UAs was 58.1 ± 33.2 µg/L; 52% of the children had UAs concentrations
> 50 µg/L, and 50.7% of children had PbB ≥ 10 µg/dL. UAs concentration was associated with low
socioeconomic status. Nutritional status indicators were not related to UAs concentrations. Linear
and logistic regressions adjusted for hemoglobin concentration, PbB, and sociodemographic con-
founders showed a signiﬁcant inverse association between UAs and Visual–Spatial Abilities with
Figure Design, the Peabody Picture Vocabulary Test, the WISC-RM Digit Span subscale, Visual
Search, and Letter Sequencing Tests (p < 0.05). Boys excreted signiﬁcantly more UAs (p < 0.05)
and were affected on different cognitive areas than girls. 
CONCLUSIONS: Children living in an area contaminated with both As and lead showed that As cont-
amination can affect children’s cognitive development, independent of any effect of lead.
KEY WORDS: arsenic, children, chronic exposition, cognitive performance, Mexico. Environ Health
Perspect 115:1371–1375 (2007). doi:10.1289/ehp.9961 available via http://dx.doi.org/ [Online
22 May 2007]Torreón, Mexico. Parents of all study subjects
gave informed written consent before being
enrolled. This study area was selected because
the foundry contributes with toxic substances
that affect a large proportion of the popula-
tion. The effects of lead exposure in this pop-
ulation have been described previously (Dorea
2004; Flora 2002; Kordas et al. 2004, 2006;
Rico et al. 2006; Rosado et al. 2006). Each
child was examined to obtain anthropometry,
nutritional status by biochemical measure-
ments in serum, levels of blood lead (PbB)
and UAs, and cognitive performance.
Complete blood and urine samples were
available for 591 children. The study was
approved by the Human Subjects Research
Committee at the Johns Hopkins Bloomberg
School of Public Health and the Institute of
Medical Sciences and Nutrition in Mexico. 
Anthropometry. Measurements were car-
ried out according to standard methods
(Habicht 1974). A trained person took all
height and weight measurements. Weight was
measured to the nearest 10 g using an upright
scale (Model Express Plus, Torino, Mexico
City, Mexico) before lunchtime to avoid vari-
ations due to immediate food ingestion.
Height was measured with a 3-m standard-
ized measurement board to the nearest 1 mm.
All participants were measured without shoes
and wearing only their school uniform with-
out any sweater or jacket. 
Biochemical measures. A venous blood
sample was collected from each child at the
school, after an overnight fast. After blood
sample collection, children were given a snack
and a juice box. Blood was collected in 5-mL
sodium heparin vacutainer trace-metal free
tubes (Becton Dickinson, Franklin Lakes, NJ,
USA). Hemoglobin (Hb) was analyzed at the
school with a HemoCue Photometer
(HemoCue Inc., Mission Viejo, CA, USA).
Samples were transported in a cooler to be
processed in the laboratory on the same day.
Serum was obtained and aliquots stored at
–80°C until analysis was done. We analyzed
serum ferritin using an immunoradiographic
method (Coat-A-count Ferritin IRMA). We
analyzed zinc and copper concentration with
an atomic absorption spectrophotometer
(PerkinElmer Analyst 700, PerkinElmer,
Norwalk, CT, USA). PbB and UAs were ana-
lyzed at the Center for Research and Advanced
Studies in the National Polytechnic Institute
in Mexico. This laboratory participates in two
quality control programs, the Trace Elements
External Quality Assessment Scheme at
University of Surrey, United Kingdom, and the
Interlaboratory Program of Quality Control at
Zaragoza, Spain. For PbB measurement, we
analyzed samples by duplicate using atomic
absorption spectrophotometry (Zeeman 5100;
PerkinElmer, Norwalk, CT, USA) (Miller
et al. 1987), and those with a CV > 5% were
re-analyzed. Lead in bovine blood (standard
reference material 955b; National Institute of
Standards and Technology, Gaithersburg,
MD, USA) was used as the standard reference.
For As measurement, a urine sample was col-
lected in the morning after subjects had fasted
overnight. It was collected in a plastic con-
tainer with 100-mL capacity. Samples were
transported with ice to the laboratory and a
25-mL aliquot was frozen at –20°C until
analysis. On the day of analysis samples were
unfrozen and warmed to 37°C in a container
with boiling water; 2.5-mL aliquots with urine
were placed in glass containers and then 2.5
mL HCl 2 M (6% w/v) was added. Samples
were covered with clock glass and heated dur-
ing 5 hr to 80°C. Then they were cooled to
room temperature and transferred to a volu-
metric ﬂask of 5 mL using HCl 2 M for dilu-
tion (Del Razo et al. 1999). The analysis was
done with an atomic absorption spectropho-
tometer (PerkinElmer 3100; PerkinElmer),
according to the procedure reported by
Crecelius et al. (1986). UAs analysis included
Rosado et al.
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Table 1. Characteristics of study participants.
Variables Value
No. 591
Percent male 54
Age (months) 83.4 ± 4.4
Socioeconomic level (%)
Low 27.5
Medium 50.1
High 22.4
Mother’s school level (%)
Primary or no education 25.6
Junior high school 55
High school or college 19.4
Weight for height: < 2 SD (%) 3
Weight for age: < 2 SD (%) 1.2
Height for age: < 2 SD (%) 2.2
Hb (g/dL) 13.4 ± 0.8
< 12.4 (%) 9.8
Ferritin (µg/L) 27.2 ± 16.1
< 12 (%) 11.7
ZPP (µmol/mol heme) 65.8 ± 22.2
≥ 70 (%) 29.3
Zinc (µg/dL) 80.1 ± 24.7
< 65 (%) 27.7
Copper (µg/dL) 106.8 ± 21.0
< 80 (%)  11
PbB concentration (µg/dL) 11.5 ± 6.3
≥ 10 (%) 50.7
InAs (ug/L) 8.7 ± 6.1
MMA (ug/L) 7.7 ± 5.2
DMA (ug/L) 41.7 ± 24.1
UAs (ug/L) 58.1 ± 33.2
UAs > 50 (%) 52.3
UAs > 100 (%) 9.8
Values are mean ± SD or percent.
Table 2. Urinary arsenic comparison among sociodemographic, hemoglobin, and PbB concentration
groups [no. (mean ± SD)]. 
Variables No. InAs MMA DMA UAs
Sex
Male 319 9.4 ± 6.9a 8.5 ± 5.5a 45.6 ± 26.0a 63.5 ± 35.9a
Female 272 7.8 ± 4.9b 6.8 ± 4.8b 37.1 ± 20.7b 51.7 ± 28.5b
SES 
Low 154 10.3 ± 6.7a 9.3 ± 5.8a 48.6 ± 26.2a 68.1 ± 36.7a
Medium 280 8.1 ± 5.6b 7.3 ± 5.0b 39.7 ± 23.8b 55.6 ± 32.4b
High 125 8.2 ± 6.4b 7.2 ± 4.7b 37.9 ± 21.4b 53.3 ± 30.2b
Mother’s school level 
Primary or no education 146 9.5 ± 6.8c 8.5 ± 5.7c 45.6 ± 25.9a 63.7 ± 35.6a
Junior high school 314 8.7 ± 6.2 7.7 ± 5.1 41.8 ± 24.5 58.0 ± 33.8
High school or college 111 7.7 ± 4.8d 7.2 ± 4.7d 37.6 ± 20.8b 52.5 ± 28.7b
Age group (years)
6 297 9.3  ± 6.8c 8.3 ± 5.4a 44.2 ± 24.9c 61.7 ± 34.7a
7–8 294 8.0  ± 5.3d 7.2 ± 4.8b 39.2 ± 23.0d 54.3 ± 31.3b
PbB concentration
≤ 10 µg/dL 293 7.8 ± 5.1a 7.1 ± 4.9a 38.5 ± 22.1a 53.4 ± 30.3a
> 10 µg/dL 297 9.6 ± 6.9b 8.4 ± 5.3b 44.7 ± 25.6b 62.6 ± 35.4b
a,bDifferent letters represent significant differences among rows at p < 0.01. c,dDifferent letters represent significant
differences among rows at p < 0.05.
Table 3. Anthropometric and nutritional variables in children with high and low total urinary arsenic
concentrations.
UAs ≥ 50 µg/L UAs < 50 µg/L
Variables No. Mean ± SD No. Mean ± SD
Height for age (Z-score) 308 –0.10 ± 0.92 281 –0.13 ± 1.02
ZPP (µmol/mol heme) 308 66.36 ± 24.99 282 65.09 ± 18.81
Hb (g/dL) 309 13.36 ± 0.81 282 13.35 ± 0.83
Ferritin (µg/dL) 290 27.31 ± 16.65 264 27.13 ± 15.55
Zinc (µg/dL) 299 78.79 ± 23.09 267 81.63 ± 26.27
Copper (µg/dL)  260 107.78 ± 20.88 239 105.75 ± 21.10
Weight (kg) 309 25.28 ± 5.47 282 24.78 ± 5.69
Height (cm) 309 120.89 ± 5.22 282 120.82 ± 5.81
Head circumference (cm) 309 50.65 ± 1.47 282 50.54 ± 1.38
Knee height (cm) 309 36.86 ± 2.05 282 36.82 ± 2.19
No signiﬁcant differences were found between groups (one-way ANOVA).InAs, monomethylarsenic (MMAs), and
dimethylarsenic (DMAs) and the sum of all
metabolic species of arsenic. Zinc proto-
porphirin (ZPP) was measured in whole
blood with ZP Hematofluorometer (AVIV
Biomedical, Lakewood, NJ, USA). 
Zinc deficiency was considered when
serum zinc was ≤ 65 mg/dL, anemia when
Hb was < 12.4 g/dL, and ferritin deficiency
≤ 12 µg/L and copper deﬁciency when serum
copper was < 80 µg/L. Elevated ZPP was con-
sidered when ≥ 70 µmol ZP/mol heme, high
As concentration when As in urinary samples
was > 50 µg/L, and PbB concentration was
considered high when > 10 µg/dL. 
Cognitive measures. Cognitive evaluations
included tests of memory, attention, problem
solving, and vocabulary processes. Each partici-
pant required two working sessions to answer
14 pen-and-paper or computer touch-screen
tests covering the various aspects of cognitive
functioning. All children had previous experi-
ence with computers. The ﬁrst session consisted
of the Coding, Digit Span, and Arithmetic sub-
tests of the Weschsler Intelligence Scale for
Children Revised Mexican Version (WISC-
RM) (Wechsler 1974, 1981), a test of number
and letter sequencing (Reitan and Wolfson
1992), and the Cognitive Abilities Test (a com-
puter-based test with four tasks: Stimulus dis-
crimination, Sternberg memory, Visual
Memory Span, and Visual Search) (Detterman
1988). These tests were all applied in this order
on day 1. Day 2 consisted of a curriculum-
based Math Achievement Test (MAT), a test of
Visual–Spatial Abilities with Figure Design,
and the Peabody Picture Vocabulary Test
(PPVT-Spanish Edition) (Dunn et al. 1986),
applied in this order. The WISC-RM and the
PPVT were validated with Mexican-American
populations; the rest of the tasks were piloted
among 1st and 2nd graders in a public elemen-
tary school in Mexico City before the project
began. Each of these tests has been described in
detail in a previous publication showing the
effects of PbB concentrations on cognitive per-
formance of these children (Kordas et al. 2004,
2006; Rico et al. 2006).
Demographics and socioeconomic status. A
questionnaire was given to parents or caregivers
of all children to identify the sociodemographic
characteristics of the families. The questionnaire
included questions to determine crowding,
housing conditions, family possessions, and
parents’ education level. These characteristics,
except parents’ education level, were used to
build a socioeconomic status (SES) index by
transforming each one into a three-category and
ordinal variable, and summing points for each
individual to build a scale between 5 and
12 points. Low SES was assigned to a sum of
5–7 points, medium SES level to 8–9 points,
and high SES to 10–12 points.
Statistical methods. We performed
statistical analysis with Stata version 8
(StataCorp., College Station, TX, USA).
Pearson correlations and analysis of variance
(ANOVA) between groups of demographic
variables were performed to evaluate their
association with UAs or the difference
between different UAs concentration (50 µg/L
cutoff). To evaluate the association of UAs
and its metabolites with cognitive perfor-
mance, we log-transformed the cognitive tests
scores when required to ﬁt a normal distribu-
tion. Three tests were omitted in the analysis:
It was not feasible to analyze the data because
variables couldn’t be normalized. Those that
fitted a normal distribution were evaluated
with linear regression models, and those that
did not were evaluated with logistic regression
at the cutoff points based on the median
value. Models were adjusted for variables that
were found to be signiﬁcantly correlated with
at least two of the cognitive tests scores at
p < 0.05: children’s age, children’s sex,
mother’s school education level, Hb concen-
tration, and PbB. The interaction between
UAs and PbB was also included in the mod-
els when it was significant at p < 0.10. The
models adjusted the standard errors for clus-
tering on children’s school to correct the
intraschool correlation. These analysis were
also performed stratified by subjects with
UAs concentration ≤ 50 µg/L and > 50 µg/L.
Because of the high influence of sex in UAs
concentrations, the models were also strati-
ﬁed for boys and girls to investigate individ-
ual effects; in these analyses sex was removed
from other adjusting variables. Collinearity
diagnosis was run for all models to confirm
the absence of multicollinearity within inde-
pendent variables. 
Results 
Demographic and biochemical characteristics
of subjects are shown in Table 1. The mean ±
SD of UAs was 58.1 ± 33.2 µg/L; 52% of the
children had UAs concentrations > 50 µg/L,
and 10% had UAs concentrations > 100
µg/L. Mean PbB concentration was 11.5 ±
6.3 µg/dL, and 50.7% of children had PbB
above 10 µg/dL. The percentages of children
with Hb, ferritin, and zinc deficiency were
9.8, 11.7, and 27.7%, respectively. 
The association of sociodemographic
variables with UAs is shown in Table 2. A sig-
nificant difference was found between boys
and girls in all As compounds: UAs was
11.85 µg/L higher in boys than in girls (p <
0.01). UAs concentration was also associated
with SES: UAs in the low SES group was sig-
nificantly higher than in medium and high
SES groups (p < 0.01). Children of parents
who had a high school or college education
excreted less UAs than children of those who
had primary or no education (p < 0.01).
Children’s age was also associated with UAs
concentration; younger children (6 years of
age) excreted more UAs and MMAs (p <
0.01) and more InAs and DMAs (p < 0.05)
than older children (7–8 years of age). PbB
correlated positively with UAs concentration
(Pearson R = 0.158, p < 0.01) (Tables 2 & 3).
Nutritional status indicators were not related
to UAs concentrations (Table 3). 
The overall unadjusted cognitive scores
stratified by UAs concentration levels are
shown in Table 4. Children in the group with
high UAs concentration presented lower
scores in 7 of 11 cognitive tests than children
with low UAs concentration.
Table 5 shows the covariate-adjusted rela-
tionship between UAs concentration and cog-
nitive performance. The analysis is also
presented separately by sex and by UAs below
and above 50 µg/L. Overall, a significant
inverse association was found between UAs
and the Visual–Spatial Abilities with Figure
Design, the PPVT, the WISC-RM Digit
Arsenic and cognitive performance in children
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Table 4. Cognitive scores of children stratiﬁed by UAs concentration [mean ± SD (minimum–maximum)].
Cognitive tests Overall Children with UAs < 50 µg/L Children with UAs > 50 µg/L
Math Achievement Test 31.35 ± 7.50 (3–52) 32.27 ± 7.69 (8–52) 30.57 ± 7.20 (3–49)*
Visual–Spatial Abilities with Figure Design 18.31 ± 5.15 (2–34) 18.88 ± 5.16 (3–34) 17.84 ± 5.08 (2–31)*
WISC-RM Arithmetic Subscale 7.41 ± 3.62 (1–17) 7.26 ± 3.66 (1–17) 7.59 ± 3.57 (1–17)
Peabody Picture Vocabulary Test 103.19 ± 15.65 (55–145) 105.20 ± 16.11 (55–145) 101.67 ± 14.92 (55–140)*
WISC-RM Digit Span Subscale 9.10 ± 3.63 (1–19) 9.46 ± 3.73 (1–19) 8.80 ± 3.55 (2–18)*
Sternberg Memory (correct trials) 12.14 ± 2.94 (4–20) 12.30 ± 3.01 (4–20) 11.98 ± 2.86 (5–20)
Visual Memory Span (correct trials) 2 ± 0.52 (0.69–3.37) 2.03 ± 0.51 (0.69–3.37) 1.97 ± 0.53 (0.69–3.26)
Stimulus Discrimination (correct trials < 19 vs. ≥ 19) 0.57 ± 0.50 (0–1) 0.63 ± 0.48 (0–1) 0.52 ± 0.50 (0–1)*
WISC-RM Coding Subscale 2.26 ± 0.59 (1–3.71) 2.29 ± 0.58 (1.07–3.71) 2.23 ± 0.61 (1–3.71)
Visual Search (correct minus incorrect minus omitted trials) 5.03 ± 1.51 (1–10.82) 5.23 ± 1.47 (1.14–10.82) 4.84 ± 1.50 (1–8.99)*
Letter Sequencing (correct trials 0 vs. ≥ 1) 0.48 ± 0.50 (0–1) 0.55 ± 0.50 (0–1) 0.41 ± 0.49 (0–1)*
*Difference between children with UAs < 50 and children UAs > 50 µg/L is signiﬁcant at p < 0.05. Rosado et al.
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Span subscale, and the Visual Search and
Letter Sequencing Tests (p < 0.05). In the
analysis stratiﬁed by UAs concentration, UAs
was significantly associated with the PPVT,
the WISC-RM Digit Span Subscale, the
Sternberg Memory Test, and the Visual
Memory Span at UAs levels ≤ 50 µg/L.
In children with UAs > 50 µg/L, the
Visual–Spatial Abilities with Figure Design,
the Stimulus Discrimination, and Letter
Sequencing Tests were signiﬁcant at p < 0.05.
For boys, the Visual–Spatial Abilities with
Figure Design and the PPVT, Visual Search,
and Letter Sequencing Tests had an inverse
association with UAs (p < 0.05). And for girls,
there was a signiﬁcant negative association of
UAs only with the WISC-RM Digit Span
Subscale (p < 0.05). The significant associa-
tions of each metabolite with the cognitive
function tests are also shown in Table 5 (type
of arsenic in parentheses). In general, organic
forms of As in urine affected more cognitive
tests than did the inorganic forms. 
Discussion
We found an association of UAs with several
cognition tests such as Visual–Spatial Abilities
with Figure Design, the PPVT, the WISC-RM
Digit Span subscale, and the Visual Search and
Letter Sequencing Tests. These associations
were independent from sociodemographic
variables, nutritional status, and PbB. When
analysis was stratified by UAs, some tests
were associated with UAs at concentrations
< 50 µg/L. However, some tests were not asso-
ciated with the high UAs group even though
the association was signiﬁcant in the low UAs
group and in the total sample; this might be
attributed to the power reduction and
increased variability in the high UAs group
compared with the variability in the low UAs
group. Cognitive tests that showed association
with UAs represent complex cognitive processes
such as memory, problem solving, and atten-
tion. Previous studies had shown an adverse
relationship between As exposure and IQ
(Calderon et al. 1999) and neurobehavioral
performance (Rodriguez et al. 2003). Results
from our study confirm earlier findings by
Calderón et al. (2001) and Tsai et al. (2003)
relating As exposure to memory alterations.
These associations occurring even in children
without elevated As concentrations could be
caused by several possible mechanisms. As
crosses the blood–brain barrier and has a wide
range of effects on the white matter in the brain
(Osterberg and Kernohan 1934). Evidence also
shows that arsenite inhibits the synthesis and
liberation of acetylcholine in brain slices
(Kobayashi et al. 1987), and increases the
monoamine activity in rat nervous system
(Mejía et al. 1997; Tripathi et al. 1997). The
increase in one monoamine, 5-hydroxyindole-3
acetic acid, is potentially neurotoxic (Jones et al.
2005; Mejía et al. 1997). Whatever the mecha-
nism, the present investigation shows that expo-
sure to As is associated with deﬁcits in cognitive
performance among school-age children, even
at low exposure levels, affecting complex cogni-
tive processes such as memory and problem
solving, which could potentially interfere with
performance at school.
We found different associations between
UAs and cognitive tests in boys and girls.
Several cognitive tests were negatively associ-
ated with UAs only in boys, and the Digit
Span subscale, an evaluation of memory, was
significantly associated with UAs only in
girls. InAs seemed to affect only boys in the
Letter Sequencing Test. According to
ANOVA to detect differences in cognitive
performance between boys and girls (data not
shown), differences in associations of cogni-
tive tests with UAs between boys and girls
did not seem to be related with differences in
sex. Although it has also been reported by
others (Chen et al. 2003; Kristiansen et al.
1997; Vahter et al. 2007), it is unclear why
boys would excrete more UAs, which thereby
affects their cognitive performance. 
Table 5. Covariate-adjusted association between UAs (µg/dL) and tests of cognitive function.
Overall Children with UAs < 50 µg/L Children with UAs > 50 µg/L Males Females
Cognitive test (n = 557) (n = 267) (n = 290) (n = 306) (n = 251)
Linear regressions [beta coefﬁcient (95% CI)]
Problem Solving and Vocabulary
Math Achievement –0.023 (–0.052 to 0.006)  –0.098* (–0.199 to 0.003)  –0.015 (–0.047 to 0.018) –0.022* (–0.046 to 0.001)  –0.019 (–0.063 to 0.026)
(MMA*) (DMA,* MMA*) (DMA,* MMA#)
Visual–Spatial Abilities with  –0.024** (–0.045 to –0.004)  –0.018 (–0.096 to 0.061) –0.028** (–0.053 to –0.004)  –0.026** (–0.048 to –0.003)  –0.019 (–0.045 to 0.007)
Figure Design (DMA**) (DMA**) (DMA*)
WISC-RM Arithmetic Subscale –0.001 (–0.016 to 0.014) –0.014 (–0.051 to 0.024) –0.006 (–0.029 to 0.016) –0.000 (–0.020 to 0.020) –0.003 (–0.021 to 0.015)
Peabody Picture Vocabulary  –0.064** (–0.115 to –0.013)  –0.185# (–0.293 to –0.078)  –0.058* (–0.120 to 0.004)  –0.058** (–0.105 to –0.010)  –0.070 (–0.169 to 0.029)
Test (InAs,** DMA,** MMA*) (DMA,** MMA*) (DMA*) (DMA,** MMA**)
Memory
WISC-RM Digit Span Subscale –0.014** (–0.025 to –0.002)  –0.037** (–0.065 to –0.010)  –0.012 (–0.037 to 0.012) –0.008 (–0.025 to 0.008) –0.039# (–0.062 to –0.016)
(DMA,* MMA**) (DMA**) (DMA,# PbB × UAs**)
Sternberg Memory  –0.002 (–0.007 to 0.004) –0.027** (–0.053 to –0.002)  0.002 (–0.008 to 0.012) 0.002 (–0.006 to 0.010) –0.008 (–0.020 to 0.005)
(correct trials) (DMA*)
Visual Memory Span  –0.000 (–0.002 to 0.001) –0.003** (–0.007 to 0.000)  –0.001 (–0.002 to 0.003) 0.000 (–0.002 to 0.002)  –0.001 (–0.004 to 0.002)
(correct trials)a (DMA**)
Attention
WISC-RM Coding Subscalea 0.000 (–0.001 to 0.000)  0.000 (–0.005 to 0.005) –0.001 (–0.003 to 0.002) 0.000 (–0.001 to 0.002) –0.002 (–0.004 to 0.001)
(DMA*)
Visual Search (correct minus  –0.007# (–0.011 to –0.002)  –0.008 (–0.022 to 0.005) –0.006* (–0.012 to 0.000)  –0.016** (–0.029 to –0.003)  0.010* (0.000 to 0.019) 
incorrect minus omitted  (InAs,# DMA,** (DMA**) (DMA,# MMA,** (PbB  × UAs#)
trials)a MMA**) PbB × UAs*)
Logistic regressions [odds ratio (95% CI)]
Memory
Stimulus Discrimination  0.998 (0.993 to 1.004) 0.982 (0.957 to 1.008) 1.004** (1.000 to 1.008)  1.002 (0.995 to 1.009) 0.990 (0.977 to 1.002)
(correct trials < 19 vs. ≥ 19) (DMA*)
Attention
Letter Sequencing  0.992# (0.987 to 0.996)  0.992 (0.963 to 1.021) 0.993** (0.988 to 0.999)  0.988# (0.982 to 0.993)  0.998 (0.990 to 1.007)
(correct trials 0 vs. ≥ 1) (DMA,# MMA#) (DMA#) (InAs,** DMA,# MMA#)
Values are beta coefﬁcient [95% conﬁdence interval (CI)] of total urinary arsenic from a multiple regression, or odds ratio from a logistic regression, with cognitive test score as the
dependent variable. Regression models were adjusted for age in months, sex, mother’s school level, Hb concentration, PbB concentration, and for PbB concentration × UAs interaction
when it was signiﬁcant at p < 0.10. CIs were adjusted for clustering on children’s school. Signiﬁcant effect of UAs metabolites on cognition functions or PbB concentration × UAs inter-
action is shown in parentheses. 
aThese cognitive tests were log-transformed to achieve the normal distribution. Beta coefﬁcient signiﬁcant at *p < 0.1, **p < 0.05, #p < 0.01.SES had an inverse association with UAs
in our study. Ahmad et al. (2001) also found
an inverse association between arsenicosis and
SES and education level, probably due to the
lack of access to As-free water. In other stud-
ies, As was also related to nutritional status of
participants. Sikder et al. (2005) found that
most of the arsenicosis patients in their study
also suffered from malnutrition. Minamoto
et al. (2005) reported that children living in
households with As-contaminated tube well
water had lower height for their age than chil-
dren living in noncontaminated households.
Similarly, Islam et al. (2004) found higher
rates of underweight in individuals with
arsenicosis than in controls, and concluded
that poor nutritional status increased the
complications of arsenicosis. In our study we
did not find an association between UAs
excretion and height, weight, and iron and
other minerals’ concentration in serum. The
lack of association was probably owing to the
fact that our subjects were generally well
nourished. Only 2% were stunted and 10%
were anemic; and the rate of children with
high concentration of UAs was the same
among anemic and nonanemic children. 
In conclusion, our study of a population of
children living in an area contaminated with
both As and lead showed that As contamina-
tion affected children’s cognitive function inde-
pendent of any effect of lead, even in children
with UAs below the safe declared concentration
limit of 50 µg/L (ATSDR 2000). 
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